Skip to main content
logo
Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
0.7996
-0.0197 (-2.40%)
Jul 29, 2026, 12:38 PM EDT - Market open

RANI Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.171.631.03--2.72
Revenue Growth
164.08%58.85%---488.10%
Gross Profit
3.171.631.03--2.72
Operating Income
-34.64-38.31-53.31-66.1-63.45-51.6
Net Income
-29.44-29.67-30.02-33.97-30.59-8.33
Earnings Per Share
-0.41-0.45-1.05-1.33-1.28-0.43
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
43.449.7127.6448.5498.48117.45
Total Debt
3.944.3229.7130.130.210
Net Cash (Debt)
39.4645.39-2.0718.4468.27117.45
Net Cash Growth
----72.99%-41.88%69.52%
Net Cash Per Share
0.380.69-0.070.722.876.01

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-18.71-18.71-35.5-51.24-46.52-32.25
Capital Expenditures
-0.09-0.09-0.27-1.23-1.62-0.51
Free Cash Flow
-18.8-18.8-35.76-52.47-48.13-32.75
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%--100.00%
Operating Margin
-1092.96%-2345.99%-5186.19%---1899.12%
Pretax Margin
-1143.17%-2507.65%-5504.28%---1953.92%
Profit Margin
-1143.17%-2507.65%-5504.28%---1953.92%
FCF Margin
0.00%-1151.38%-3478.99%---1205.41%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
32.03100.5244.39--118.62